Urikal (1500 mg+250 mg)/5 ml (Oral Solution)

Title

• Urikal Oral Solution

Categories

• Medicine
• UTI Relief
• Kidney Stone Prevention
• Gout Prevention
• Acidosis Treatment

Description

• A stable and pleasant-tasting oral systemic alkalizer
• Highly palatable and tolerable for long-term use
• Does not neutralize gastric juice or disturb digestion

Indications

• Relief of discomfort in urinary tract infections
• Prevention of kidney stones
• Prevention of gout when used with uricosuric agent
• Treatment of acidosis caused by kidney diseases

Pharmacology

• Potassium Citrate and Citric Acid oral solution
• Metabolizes to Potassium Bicarbonate
• Alkalinizes urine without producing systemic alkalosis

Dosage & Administration

• Adults over 6 years: 10 ml 3 times daily, diluted with water
• Children 1-6 years: 5 ml 3 times daily, diluted with water
• Adults for kidney stones/gout/acidosis: 10-15 ml 4 times daily, diluted with water
• Pediatric for kidney stones/gout/acidosis: 5-10 ml 4 times daily, diluted with water

Interaction

• Concurrent administration with potassium-containing medication may lead to toxicity
• Caution with potassium-sparing diuretics, ACE inhibitors, and cardiac glycosides

Contraindications

• Severe renal impairment with oliguria or azotemia
• Untreated Addison's disease
• Acute dehydration
• Severe myocardial damage
• Hyperkalemia from any cause

Side Effects

• Well tolerated in patients with normal renal function
• Caution needed in patients with abnormal renal mechanisms to avoid hyperkalemia or alkalosis
• Possible symptoms of potassium intoxication

Pregnancy & Lactation

• No available information for use during pregnancy and lactation

Precautions & Warnings

• Use with caution in patients with low urinary output
• Dilute adequately to minimize gastrointestinal injury
• Preferably take each dose after meals
• Large doses may cause hyperkalemia and alkalosis, especially with renal disease

Overdose Effects

• Rarely causes serious hyperkalemia in persons with normal potassium excretory mechanisms
• Treatment measures including elimination of potassium sources, dextrose solution with insulin, and dialysis if hyperkalemia occurs

Therapeutic Class

• Prevention of repeated kidney stone formation
• Urinary Alkalinizing Agent

Storage Conditions

• Keep below 30°C, away from light and moisture
• Keep out of the reach of children

Related Brands

• Citra-K (1500 mg+250 mg)/5 ml (Oral Solution) - unimed-unihealth-pharmaceuticals-ltd